Weiss Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-795	Closed	-$363K	–	580
2025 Q3	$363K	Buy	+795	New	+$324K	0.01%	516
2024 Q3	–	Sell	-23,800	Closed	-$5.78M	–	600
2024 Q2	$5.78M	Sell	23,800 -876	-4%	-$138K	0.28%	99
2024 Q1	$3.69M	Buy	24,676 +23,484	+1,970%	+$3.92M	0.17%	138
2023 Q4	$228K	Buy	+1,192	New	+$203K	0.02%	292
2022 Q4	–	Sell	-24,450	Closed	-$4.89M	–	544
2022 Q3	$4.89M	Buy	+24,450	New	+$4.66M	0.13%	240
2018 Q4	–	Sell	-2,460	Closed	-$215K	–	456
2018 Q3	$215K	Hold	2,460	–	–	0.02%	145
2018 Q2	$242K	Hold	2,460	–	–	0.03%	132
2018 Q1	$293K	Hold	2,460	–	–	0.03%	143
2017 Q4	$313K	Buy	+2,460	New	+$309K	0.03%	159